Aptinyx Inc

-0.05 (-8.69%)
Earnings Announcements

Aptinyx Reports Q1 2022 Results

Published: 05/12/2022 20:37 GMT
Aptinyx Inc (APTX) - Aptinyx Reports First Quarter 2022 Financial Results and Highlights Recent Clinical Progress.
Cash and Cash Equivalents Were $100.2 Million at March 31, 2022, Compared to $106.1 Million at December 31, 2021.
Qtrly Net Loss per Share - Basic and Diluted $0.29.
Q1 Earnings per Share View $-0.30 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.23

More details on our Analysts Page.